In pursuit of both time and cost savings, as well as to
mitigate the regulatory challenges associated with manufacturing of cell
therapy consumables, around 90% of the cell therapy developers prefer to
outsource culture media, kits, reagents and extracellular matrices to
consumable providers, which
claim to have the required expertise in order to yield high quality raw
materials.
The
financial opportunity within the cell therapy media markethas been analyzed across the following segments:
§ Type of Produc...
more